EN | 中文
DiaCarta, Inc

Based in Hayward, CA, DiaCarta is a commercial stage, revenue-generating company focused on selling the most precise molecular diagnostic cancer assays, a $5+ billion global market growing over 10% per year. Through a combination of licensed technology and additional proprietary product development, DiaCarta has developed some of the most sensitive tests on the market; QClamp for detecting a broad set of somatic gene mutations and QuantiVirus® HPV E6/E7 mRNA for detecting high-risk oncogenes for cervical cancer in women and head and neck cancer in men.